Clinical Trial Update: Neoadjuvant Concurrent Chemoradiation With Weekly Docetaxel/Cisplatin for Resectable IIIA-N2 NSCLC [Phase 2]

View source ↗

Summary

This document provides a Phase 2 trial update on neoadjuvant concurrent chemoradiation with weekly docetaxel and cisplatin for resectable IIIA-N2 non-small cell…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• DOCETAXEL (DOCETAXEL)

Snippet

Sponsor: Peking University People's Hospital | Conditions: Non-small Cell Lung Cancer | Phase 2 | Status: UNKNOWN